Metherdac 0.2mg Injection
Marketer
Innovative Pharmaceuticals
Salt Composition
Methylergometrine (0.2mg)
Overview Metherdac 0.2mg Injection
Uterine bleeding following childbirth or termination of pregnancy may be managed with Metherdac 0.2mg Injection. This medication acts on uterine smooth muscle, augmenting contractile tone, frequency, and strength to minimize hemorrhage. Administration is strictly by a physician in a hospital setting via intravenous or intramuscular injection; self-administration is prohibited. Dosage and frequency are individualized based on the patient's condition and determined by the prescribing physician to optimize symptom control. Common adverse effects include headache, hypertension, and convulsions. Report any concerning or persistent side effects to your doctor; management strategies may be available. Concurrent alcohol consumption is generally discouraged. Prior to treatment initiation, disclose any history of cardiovascular disease or hypertension. Comprehensive information regarding all other medications currently in use should also be provided, as drug interactions could compromise efficacy or alter the drug's effects.
Primary Ingredients of Metherdac 0.2mg Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Metherdac 0.2mg Injection
Hemorrhage postpartum
Major Benefits of Metherdac 0.2mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Metherdac 0.2mg Injection:
- High blood pressure
- Headache
- Seizure
How to use Metherdac 0.2mg Injection:
Administering this medication will be performed by your healthcare provider. Self-medication is strictly prohibited.
How Metherdac 0.2mg Injection works:
Metherdac 0.2mg Injection, an ergot derivative, induces prolonged uterine smooth muscle contraction. This vascular compression effectively manages postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Metherdac 0.2mg Injection may be unsafe; seek medical advice before combining them.
PregnancyUNSAFE
Administering Metherdac 0.2mg Injection to pregnant individuals presents a considerable risk. Pregnant women should consult their physician before use, as research in animal and human subjects indicates substantial adverse consequences for fetal development.
Breast feedingCAUTION
Administering Metherdac 0.2mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingCONSULT YOUR DOCTOR
The effect of Metherdac 0.2mg Injection on driving ability is undetermined. Refrain from operating a vehicle if you encounter symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Metherdac 0.2mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Metherdac 0.2mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Metherdac 0.2mg Injection :
NA
Facts to Know About Metherdac 0.2mg Injection
| Label | Value |
|---|---|
| Chemical Category | Ergoline alkaloids |
| Developing Habits | No. |
| Treatment Category | OBSTETRIC AND GYNECOLOGICAL |
| Actions | Drugs inducing uterine contraction and abortion |
3,018 People bought this recently